RYZ101

· RayzeBio, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for RYZ101, covering 2026-03-18 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma [Phase 1, Phase 2]